Nalaganje...

Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab

FKB327 was approved by the European Medicines Agency as a biosimilar to European‐authorized adalimumab (Humira(®); AbbVie Inc). Adalimumab is a monoclonal antibody, binding and inhibiting tumor necrosis factor (TNF)‐α with use indicated for several immune‐mediated, chronic, and inflammatory disorder...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pharmacol Res Perspect
Main Authors: Schreiber, Stefan, Yamamoto, Katsuhiko, Muniz, Rafael, Iwura, Takafumi
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7272391/
https://ncbi.nlm.nih.gov/pubmed/32500668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.604
Oznake: Označite
Brez oznak, prvi označite!